Evidence map›Paper›PMID 35659391›Full record

ArticleArtificial intelligence in medicine2022

Hybrid learning method based on feature clustering and scoring for enhanced COVID-19 breath analysis by an electronic nose.

Shidiq Nur Hidayat, Trisna Julian, Agus Budi Dharmawan, Mayumi Puspita, Lily Chandra, Abdul Rohman, Madarina Julia, Aditya Rianjanu, Dian Kesumapramudya Nurputra, Kuwat Triyana and 1 more

Open access · greenAbstract read
In one paragraph

Article in Artificial intelligence in medicine, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed, 2 pooled it
4.1field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 2 syntheses or guidelines pooled it, 51 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Review
  12. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 3 institutions in 1 country.

Shidiq Nur HidayatPT Nanosense Instrument Indonesia, Umbulharjo, Yogyakarta 55167, Indonesia; Department of Physics, Faculty of Mathematics and Natural Sciences, Universitas Gadjah Mada, Sekip Utara, BLS 21, Yogyakarta 55281, Indonesia.
Trisna JulianPT Nanosense Instrument Indonesia, Umbulharjo, Yogyakarta 55167, Indonesia.
Agus Budi DharmawanPT Nanosense Instrument Indonesia, Umbulharjo, Yogyakarta 55167, Indonesia; Faculty of Information Technology, Universitas Tarumanagara, Jl. Letjen S. Parman No. 1, Jakarta 11440, Indonesia.
Mayumi PuspitaPT Nanosense Instrument Indonesia, Umbulharjo, Yogyakarta 55167, Indonesia.
Lily ChandraRS Bhayangkara Polda Daerah Istimewa Yogyakarta, Jl. Raya Solo-Yogyakarta KM. 14, Sleman 55571, Indonesia.
Abdul RohmanDepartment of Pharmaceutical Chemistry, Faculty of Pharmacy, Universitas Gadjah Mada, Jl. Farmako Sekip Utara, Yogyakarta 55281, Indonesia.
Madarina JuliaDepartment of Child Health, Faculty of Medicine, Public Health and Nursing, Universitas Gadjah Mada, Jl. Farmako Sekip Utara, Yogyakarta 55281, Indonesia.
Aditya RianjanuDepartment of Materials Engineering, Institut Teknologi Sumatera, Terusan Ryacudu, Way Hui, Jati Agung, Lampung 35365, Indonesia.
Dian Kesumapramudya NurputraDepartment of Child Health, Faculty of Medicine, Public Health and Nursing, Universitas Gadjah Mada, Jl. Farmako Sekip Utara, Yogyakarta 55281, Indonesia.
Kuwat TriyanaDepartment of Physics, Faculty of Mathematics and Natural Sciences, Universitas Gadjah Mada, Sekip Utara, BLS 21, Yogyakarta 55281, Indonesia. Electronic address: triyana@ugm.ac.id.
Hutomo Suryo WasistoPT Nanosense Instrument Indonesia, Umbulharjo, Yogyakarta 55167, Indonesia.
Universitas Gadjah Mada · IDSumatera Institute of Technology · IDTarumanagara University · ID

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Breath pattern analysis based on an electronic nose (e-nose), which is a noninvasive, fast, and low-cost method, has been continuously used for detecting human diseases, including the coronavirus disease 2019 (COVID-19). Nevertheless, having big data with several available features is not always beneficial because only a few of them will be relevant and useful to distinguish different breath samples (i.e., positive and negative COVID-19 samples). In this study, we develop a hybrid machine learning-based algorithm combining hierarchical agglomerative clustering analysis and permutation feature importance method to improve the data analysis of a portable e-nose for COVID-19 detection (GeNose C19). Utilizing this learning approach, we can obtain an effective and optimum feature combination, enabling the reduction by half of the number of employed sensors without downgrading the classification model performance. Based on the cross-validation test results on the training data, the hybrid algorithm can result in accuracy, sensitivity, and specificity values of (86 ± 3)%, (88 ± 6)%, and (84 ± 6)%, respectively. Meanwhile, for the testing data, a value of 87% is obtained for all the three metrics. These results exhibit the feasibility of using this hybrid filter-wrapper feature-selection method to pave the way for optimizing the GeNose C19 performance.

Indexed as

COVID-19Electronic NoseBreath TestsCluster AnalysisHumansMachine LearningBreath analysisElectronic noseFeature permutation importanceGeNose C19Hierarchical agglomerative clusteringMachine learning

Identifiers

PMID35659391
PMCPMC9110307
OpenAlexW4280572530

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.